Investors

We’re dsm-firmenich – innovators in nutrition, health, and beauty

dsm-firmenich at a glance

Two global leaders in science and innovation, each with a world-class portfolio, have come together to create dsm-firmenich. Our roots may go back well over a century, but we’re always looking forward.

Financial calendar

April 30, 2025
Q1 2025 trading update

May 6, 2025
Annual General Shareholders Meeting

July 31, 2025
H1 2025 results

Purpose-driven performance

dsm-firmenich brings together two iconic companies. We have deep roots and a bright future, with shared strengths and unrivaled expertise that drive positive impact in everything we do. Our purpose is to bring progress to life – creating a world of potential for customers, communities, consumers, and investors.
1355524615

dsm-firmenich reports Full Year 2024 results

dsm-firmenich announced its full year 2024 results on February 13, 2025.

Share price:

Contact Investor relations

Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.

EMTN Program Documents

Discover and read about our EMTN Program related documents.

Latest news
  • 22 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • 15 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

  • 8 April 2025

    Weekly progress on share repurchase program to cover share plans and reduce capital

Explore more
  • dsm-firmenich at a glance

    Who we are. Why we merged. Where we’re going.

  • Share center

    All the key details on holding and trading shares of dsm-firmenich.